These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3874172)

  • 21. T-lymphocyte subsets in idiopathic dilated cardiomyopathy.
    Sanderson JE; Koech D; Iha D; Ojiambo HP
    Am J Cardiol; 1985 Mar; 55(6):755-8. PubMed ID: 3156482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological defects precursors of myocarditis and dilated cardiomyopathy?
    Bolte HD
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():69-71. PubMed ID: 3162035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of T-lymphocyte subpopulations in dilated myocardiopathy].
    Pallarés C; Blanchs L; Gausí C; Buendía E
    Med Clin (Barc); 1985 Mar; 84(8):336-7. PubMed ID: 3872390
    [No Abstract]   [Full Text] [Related]  

  • 24. Cellular immunity in congestive cardiomyopathy. Hypersensitivity to cardiac antigens.
    Lowry PJ; Thompson RA; Littler WA
    Br Heart J; 1985 Apr; 53(4):400-4. PubMed ID: 3885980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity in dilated cardiomyopathy.
    Das SK; Cassidy JT; Huber SA
    Heart Vessels Suppl; 1985; 1():205-8. PubMed ID: 2956236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy.
    Gerli R; Rambotti P; Spinozzi F; Bertotto A; Chiodini V; Solinas P; Gernini I; Davis S
    Am Heart J; 1986 Aug; 112(2):350-5. PubMed ID: 2943148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological cellular regulator and effector mechanisms in myocarditis.
    Maisch B; Bülowius U; Schmier K; Klopf D; Koper D; Sibelis T; Kochsiek K
    Herz; 1985 Feb; 10(1):8-14. PubMed ID: 2858443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relation between helper and suppressive/cytotoxic T lymphocytes in the peripheral blood in patients with dilated cardiomyopathy].
    Smalcelj A; Duraković Z; Batinić D; Bogdan I; Grgić V
    Acta Med Iugosl; 1991; 45(1):3-13. PubMed ID: 1827936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoregulatory lymphocyte subpopulations in patients with dilated and hypertrophic cardiomyopathies].
    Chumburidze VB; Iurenev AP; Tabazari DZ; Dzidziguri LM; Krukovskaia ZV
    Ter Arkh; 1986; 58(10):59-62. PubMed ID: 2879362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune function during ageing in man: relation between serological abnormalities and cellular immune status.
    Lokhorst HM; van der Linden JA; Schuurman HJ; Gmelig Meyling FH; Bast EJ; de Gast GC
    Eur J Clin Invest; 1983 Jun; 13(3):209-14. PubMed ID: 6409645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-lymphocyte subsets as noninvasive markers of cardiomyopathy.
    Kanda T; Yokoyama T; Ohshima S; Yuasa K; Watanabe T; Suzuki T; Murata K
    Clin Cardiol; 1990 Sep; 13(9):617-22. PubMed ID: 2145109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression.
    Kuethe F; Braun RK; Foerster M; Schlenker Y; Sigusch HH; Kroegel C; Figulla HR
    J Clin Immunol; 2006 Jan; 26(1):33-9. PubMed ID: 16418801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dilated cardiomyopathy--a chronic myocarditis? Immunohistological characterization of lymphocytic infiltrates].
    Kühl U; Daun B; Seeberg B; Schultheiss HP; Strauer BE
    Herz; 1992 Apr; 17(2):97-106. PubMed ID: 1577368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of immunological studies in various forms of cardiomyopathy].
    Iurenev AP; Chumburidze VB; Polianskaia IS; Iazdovskiĭ VV; Krukovskaia ZV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):101-6. PubMed ID: 3501296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR antigen linkage of anti-beta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy.
    Limas CJ; Limas C
    Br Heart J; 1992 May; 67(5):402-5. PubMed ID: 1327038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemistry in dilated cardiomyopathy.
    Kühl U; Noutsias M; Schultheiss HP
    Eur Heart J; 1995 Dec; 16 Suppl O():100-6. PubMed ID: 8682073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.
    Maisch B; Deeg P; Liebau G; Kochsiek K
    Am J Cardiol; 1983 Nov; 52(8):1072-8. PubMed ID: 6356861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy.
    Noutsias M; Pauschinger M; Schultheiss H; K hl U
    Med Sci Monit; 2002 Jul; 8(7):CR478-87. PubMed ID: 12118194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.
    Kurz P; Köhler H; Meuer S; Hütteroth T; Meyer zum Büschenfelde KH
    Kidney Int; 1986 Jun; 29(6):1209-14. PubMed ID: 3489122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological disorders in patients with dilated cardiomyopathy. With special reference to the production of interleukin-2 and the expression of interleukin-2 receptors in the patients' peripheral blood lymphocytes.
    Koike S
    Jpn Heart J; 1989 Nov; 30(6):799-807. PubMed ID: 2632833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.